Human cytomegalovirus (HCMV) DNAemia in the mother at amniocentesis as a risk factor for iatrogenic HCMV infection of the fetus

J Infect Dis. 2008 Feb 15;197(4):593-6. doi: 10.1086/526499.

Abstract

To investigate whether invasive procedures performed in the presence of human cytomegalovirus (HCMV) DNA in maternal peripheral blood (HCMV DNAemia) represent a risk for iatrogenic transmission of HCMV infection to the fetus, 194 pregnant women undergoing prenatal diagnosis because of a primary HCMV infection and their 199 fetuses were investigated. Overall, 27 (37%) of 73 mothers of uninfected fetuses and 22 (37%) of 59 mothers of infected fetuses were HCMV DNAemia-positive at amniocentesis. Of the 8 mothers of the 8 fetuses with false-negative amniocentesis results, 4 were DNAemia-positive and 4 were DNAemia-negative at amniocentesis. Therefore, maternal HCMV DNAemia is not a significant risk factor for iatrogenic HCMV transmission to the fetus during amniocentesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amniocentesis / adverse effects*
  • Biomarkers
  • Cohort Studies
  • Cytomegalovirus
  • Cytomegalovirus Infections / transmission*
  • DNA, Viral / blood*
  • False Negative Reactions
  • Female
  • Gestational Age
  • Humans
  • Iatrogenic Disease
  • Infectious Disease Transmission, Vertical*
  • Pregnancy
  • Prenatal Diagnosis
  • Retrospective Studies

Substances

  • Biomarkers
  • DNA, Viral